Hemab Therapeutics · 2 days ago
Director Biostatistics
Hemab Therapeutics is a clinical-stage biotech company focused on addressing the needs of patients suffering from rare bleeding and thrombotic disorders. As the Director of Biostatistics, you will develop statistical strategies for clinical programs and lead cross-functional collaborations, ensuring scientific rigor and regulatory compliance throughout the development process.
BiotechnologyLife ScienceMedicalPharmaceutical
Responsibilities
Lead statistical input for clinical development plans, protocol design, endpoint selection, data analysis and interpretation
Develop innovative trial designs including but not limited to adaptive, and Bayesian approaches to maximize learning from limited patient populations
Author and review Statistical Analysis Plans (SAPs) and statistical sections of regulatory documents, and perform statistical analyses to inform decision making
Develop quantitative decision frameworks for dose-finding and proof-of-concept studies
Provide strategic statistical guidance for go/no-go decisions and portfolio prioritization
Prepare statistical components for regulatory submissions (INDs, NDAs/BLAs, CSRs)
Oversee CRO statistical deliverables and vendor relationships
Lead cross-functional collaboration with Clinical Research, Clinical Pharmacology, Clinical Operations, Data Management, Regulatory Affairs, and Medical Affairs
Foster innovation in statistical methodology and process improvement
Mentor/manage junior statistician(s)
Qualification
Required
PhD in Statistics/Biostatistics with 8+ years for Director pharmaceutical/biotech industry experience, OR Master's degree in Statistics/Biostatistics with 12+ years pharmaceutical/biotech industry experience
Extensive clinical development experience from early to late stage is required
Demonstrated ability to influence clinical development strategy and executive decision-making
Excellent communication skills with ability to present complex statistical concepts to non-statistical audiences
Experience with adaptive trial designs, Bayesian methods, and simulation techniques
Strong project management skills handling multiple concurrent programs
Preferred
NDA/BLA submission experience strongly preferred
Direct experience with rare disease or hematology clinical trials highly desirable
Company
Hemab Therapeutics
Hemab is a clinical-stage biotech company developing the first prophylactic therapeutics for serious, underserved bleeding and thrombotic disorders.
Funding
Current Stage
Growth StageTotal Funding
$347MKey Investors
Sofinnova PartnersAccess BiotechnologyNovo Holdings
2025-10-27Series C· $157M
2023-02-21Series B· $135M
2021-07-22Series A· $55M
Recent News
2025-11-19
Company data provided by crunchbase